Literature DB >> 26040991

Zn(II) and Hg(II) binding to a designed peptide that accommodates different coordination geometries.

Dániel Szunyogh1, Béla Gyurcsik, Flemming H Larsen, Monika Stachura, Peter W Thulstrup, Lars Hemmingsen, Attila Jancsó.   

Abstract

Designed metal ion binding peptides offer a variety of applications in both basic science as model systems of more complex metalloproteins, and in biotechnology, e.g. in bioremediation of toxic metal ions, biomining or as artificial enzymes. In this work a peptide (HS: Ac-SCHGDQGSDCSI-NH2) has been specifically designed for binding of both Zn(II) and Hg(II), i.e. metal ions with different preferences in terms of coordination number, coordination geometry, and to some extent ligand composition. It is demonstrated that HS accommodates both metal ions, and the first coordination sphere, metal ion exchange between peptides, and speciation are characterized as a function of pH using UV-absorption-, synchrotron radiation CD-, (1)H-NMR-, and PAC-spectroscopy as well as potentiometry. Hg(II) binds to the peptide with very high affinity in a {HgS2} coordination geometry, bringing together the two cysteinates close to each end of the peptide in a loop structure. Despite the high affinity, Hg(II) is kinetically labile, exchanging between peptides on the subsecond timescale, as indicated by line broadening in (1)H-NMR. The Zn(II)-HS system displays more complex speciation, involving monomeric species with coordinating cysteinates, histidine, and a solvent water molecule, as well as HS-Zn(II)-HS complexes. In summary, the HS peptide displays conformational flexibility, contains many typical metal ion binding groups, and is able to accommodate metal ions with different structural and ligand preferences with high affinity. As such, the HS peptide may be a scaffold offering binding of a variety of metal ions, and potentially serve for metal ion sequestration in biotechnological applications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26040991     DOI: 10.1039/c5dt00945f

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  7 in total

1.  Structure-Activity Relationships in Metal-Binding Pharmacophores for Influenza Endonuclease.

Authors:  Cy V Credille; Benjamin L Dick; Christine N Morrison; Ryjul W Stokes; Rebecca N Adamek; Nicholas C Wu; Ian A Wilson; Seth M Cohen
Journal:  J Med Chem       Date:  2018-10-31       Impact factor: 7.446

2.  A study on the secondary structure of the metalloregulatory protein CueR: effect of pH, metal ions and DNA.

Authors:  Ria K Balogh; Eszter Németh; Nykola C Jones; Søren Vrønning Hoffmann; Attila Jancsó; Béla Gyurcsik
Journal:  Eur Biophys J       Date:  2021-04-28       Impact factor: 1.733

3.  Oxytocin-Monolayer-Based Impedimetric Biosensor for Zinc and Copper Ions.

Authors:  Kiran Kumar Tadi; Israel Alshanski; Evgeniy Mervinetsky; Gerard Marx; Panayiota Petrou; Karussis M Dimitrios; Chaim Gilon; Mattan Hurevich; Shlomo Yitzchaik
Journal:  ACS Omega       Date:  2017-12-08

4.  C-terminal Cysteines of CueR Act as Auxiliary Metal Site Ligands upon HgII Binding-A Mechanism To Prevent Transcriptional Activation by Divalent Metal Ions?

Authors:  Ria K Balogh; Béla Gyurcsik; Éva Hunyadi-Gulyás; Juliana Schell; Peter W Thulstrup; Lars Hemmingsen; Attila Jancsó
Journal:  Chemistry       Date:  2019-10-15       Impact factor: 5.236

5.  Metal Binding Ability of Small Peptides Containing Cysteine Residues.

Authors:  Márton Lukács; Dóra Csilla Pálinkás; Györgyi Szunyog; Katalin Várnagy
Journal:  ChemistryOpen       Date:  2021-04       Impact factor: 2.630

6.  Tying Up a Loose End: On the Role of the C-Terminal CCHHRAG Fragment of the Metalloregulator CueR.

Authors:  Ria K Balogh; Béla Gyurcsik; Mikael Jensen; Peter W Thulstrup; Ulli Köster; Niels Johan Christensen; Marianne L Jensen; Éva Hunyadi-Gulyás; Lars Hemmingsen; Attila Jancsó
Journal:  Chembiochem       Date:  2022-07-05       Impact factor: 3.461

Review 7.  Metal-Coordinated Supramolecular Self-Assemblies for Cancer Theranostics.

Authors:  Jiating Xu; Jun Wang; Jin Ye; Jiao Jiao; Zhiguo Liu; Chunjian Zhao; Bin Li; Yujie Fu
Journal:  Adv Sci (Weinh)       Date:  2021-06-18       Impact factor: 16.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.